Published: Guidance, quality standards and advice
Showing 1131 to 1140 of 1525
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma | TA544 | ||
| Lyme disease | NG95 | ||
| Renal replacement therapy services for adults | QS72 | ||
| Cabozantinib for untreated advanced renal cell carcinoma | TA542 | ||
| Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs | TA543 | ||
| Renal replacement therapy and conservative management | NG107 | ||
| Decision-making and mental capacity | NG108 | ||
| myAIRVO2 for the treatment of chronic obstructive pulmonary disease | MIB161 | ||
| E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta | HTG326 | ||
| OxyMask for delivering oxygen therapy | MIB160 |